Pharmaids Pharmaceuticals Ltd. - Research Center
524572 PHARMAID Group (X) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Sales |
- |
- |
1.03 |
2.91 |
3.26 |
Operating profit |
-2.63 |
-0.59 |
0.01 |
0.12 |
0.05 |
Interest |
- |
- |
- |
- |
- |
Gross profit |
-2.52 |
-0.59 |
0.03 |
0.12 |
0.07 |
EPS (Rs) |
-0.84 |
-0.67 |
0.02 |
0.08 |
0.04 |
Half yearly
results in details
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Other income |
0.11 |
- |
0.02 |
- |
0.03 |
Stock adjustment |
- |
- |
-0.10 |
-0.42 |
-0.70 |
Raw material |
- |
- |
- |
- |
- |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
0.83 |
0.34 |
0.07 |
0.04 |
0.01 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
1.79 |
0.25 |
1.05 |
3.17 |
3.90 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
0.02 |
0.01 |
- |
0.01 |
0.02 |
Taxation |
-0.69 |
0.09 |
- |
0.03 |
0.01 |
Net profit / loss |
-1.80 |
-0.69 |
0.02 |
0.08 |
0.04 |
Extra ordinary item |
0.04 |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
21.44 |
10.31 |
10.31 |
10.31 |
10.27 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
- |
- |
1.08 |
4.23 |
1.47 |
GPM (%) |
- |
- |
2.52 |
- |
2.26 |
NPM (%) |
- |
- |
2.22 |
- |
1.24 |